Reshape, a Copenhagen, Denmark-based company that provides an AI and robotics-powered imaging and analysis platform, raised $20 million in Series A funding.
Investors
The round was led by Astanor Ventures, R7, ACME, Y Combinator, Unity Co-Founder Nicholas Francis, and Per Falholt.
Astanor Ventures is a venture capital firm focusing on entrepreneurs regenerating the food, blue ocean economy, and agriculture sectors.
Founded in 2013, R7 is a venture capital firm based in Chicago, Illinois. The firm prefers to invest in seed-stage, early-stage, and later-stage companies.
Y Combinator is a technology startup accelerator and venture capital firm that invests in a large number of startups twice a year. It created a new model for funding startups.
Reshape Use of Funds
The company will use the funding to expand operations and continue automating research and development processes for agricultural, industrial, and biotech organizations.
About Reshape
Founded in 2018 by Carl-Emil Grøn, Daniel Storgaard, and Magnus Nyborg Madsen, Reshape is a company that provides AI technology for biological research aimed at addressing some of the world’s most pressing challenges, such as sustainable nutrition and agriculture, disease treatment in a growing population, and the conservation of our planet’s biodiversity. Reshape enables biological researchers to automate visual experiments by capturing and analyzing data points instantly and accurately. The company’s technology is already used by dozens of leading organizations including Syngenta, University of Oxford, Novozymes, and others.
Funding Details
Company: Reshape ApS
Raised: $20.0M
Round: Series A
Funding Month: April 2024
Lead Investors: Astanor Ventures, R7, ACME, Y Combinator, Unity Co-Founder Nicholas Francis, Per Falholt Coatue
Additional Investors:
Company Website: https://www.reshapebiotech.com/
Software Category: AI-Powered Imaging and Analysis Platform
Source: https://www.webwire.com/ViewPressRel.asp?aId=320261